PD-1 checkpoint inhibitor (argenx)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePD-1 checkpoint inhibitor (argenx)
Drug Alias NameAnti-programmed cell death 1 antibody (argenx)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProgrammed cell death protein 1 modulators
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArgenx Se
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArgenx Se
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A